Portsmouth, United States
Novalis LifeSciences is a boutique investment and advisory firm for the Life Science industry that was founded in 2017 by Marijn E. Dekkers. With a team of experienced operating executives from the Life Science industry, Novalis funds and advises visionary Life Science entrepreneurs. In addition to making financial investments, Novalis provides strategic and operational advice to portfolio companies that are at a critical growth stage in their development.
21
Total Investments
15
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Novalis LifeSciences
Recent Investments (21)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series B | •••••• | Sep 2025 | |
| Seed Round | •••••• | Sep 2023 | |
| Series D | •••••• | Jun 2023 | |
| Post-IPO Equity | •••••• | May 2023 | |
| Series A | •••••• | Apr 2023 | |
•••• ••••
|
Series B | •••••• | Apr 2023 |
|
•••• ••••
|
Series C | •••••• | Oct 2022 |
|
•••• ••••
|
Series B | •••••• | Aug 2022 |
|
•••• ••••
|
Series C | •••••• | Jul 2022 |
|
•••• ••••
|
Series B | •••••• | Jul 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
